CompletedPhase 2ketamine
Intranasal Ketamine as a Sedative for Venipuncture
Sponsored by Hospital de Clinicas de Porto Alegre
NCT ID
NCT02929524
Target Enrollment
39 participants
Start Date
2015-04
Est. Completion
2016-10
About This Study
Randomized clinical trial, controlled, double-blind, parallel two-arm.
Conditions Studied
Interventions
- •Ketamine
- •Placebo
Eligibility
Age:3 Months - 12 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Children hospitalized in the Pediatric Inpatient Units, with the presence of legal guardian; * Aged 3 months to 12 years; * Requiring venipuncture independent research. Exclusion Criteria: * Severe neurological sequelae; * Patients who need immediate venipuncture at risk; * Presence of active nosebleeds; * Patients using drugs sedative and analgesic continuos; * Children who have experienced clinical change with ketamine.